ES2160090B1 - Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration - Google Patents
Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administrationInfo
- Publication number
- ES2160090B1 ES2160090B1 ES200000635A ES200000635A ES2160090B1 ES 2160090 B1 ES2160090 B1 ES 2160090B1 ES 200000635 A ES200000635 A ES 200000635A ES 200000635 A ES200000635 A ES 200000635A ES 2160090 B1 ES2160090 B1 ES 2160090B1
- Authority
- ES
- Spain
- Prior art keywords
- cyprofloxacin
- otitis
- aqueous
- single dose
- comprises single
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The set of aqueous cyprofloxacin otitis pharmaceuticals comprising single-dose products for treatment of perforated-eardrum patients, is new. Also claimed is a process utilizing the products in the form of droplets, topically, from single-dose containers.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200000635A ES2160090B1 (en) | 2000-03-16 | 2000-03-16 | Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200000635A ES2160090B1 (en) | 2000-03-16 | 2000-03-16 | Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2160090A1 ES2160090A1 (en) | 2001-10-16 |
ES2160090B1 true ES2160090B1 (en) | 2002-07-01 |
Family
ID=8492728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200000635A Expired - Fee Related ES2160090B1 (en) | 2000-03-16 | 2000-03-16 | Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2160090B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050159369A1 (en) * | 2003-08-20 | 2005-07-21 | Qtm Llc | Method of treatment of otitis externa |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2088742B1 (en) * | 1994-06-29 | 1997-03-16 | Salvat Lab Sa | ANTIBIOTIC COMPOSITION OF OTIC APPLICATION. |
US5843930A (en) * | 1995-06-06 | 1998-12-01 | Bayer Corporation | Method of treating otitis with ciprofloxacin-hydrocortisone suspension |
DE69620136T2 (en) * | 1995-06-06 | 2002-08-01 | Bayer Ag | ANTIBACTERIAL PREPARATIONS FOR THE EARS WITHOUT IRRITATING, SENSITIZING AND OTOTOXIC EFFECTS |
IT1280428B1 (en) * | 1995-07-14 | 1998-01-20 | R R A S R L | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE |
ES2105971B1 (en) * | 1995-08-02 | 1998-07-01 | S A L V A T Lab Sa | ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION. |
ES2105970B1 (en) * | 1995-08-02 | 1998-07-01 | S A L V A T Lab Sa | ORAL PHARMACEUTICAL COMPOSITION OF CIPROFLOXACINO, NON-AQUEOUS, STABLE AND WITH IMPROVED ORGANOLEPTIC CHARACTERISTICS. |
ES2106680B1 (en) * | 1995-08-03 | 1998-07-01 | Vita Invest Sa | AQUEOUS COMPOSITIONS CONTAINING CIPROFLOXACINO AND CORRESPONDING USE AND PROCEDURE. |
-
2000
- 2000-03-16 ES ES200000635A patent/ES2160090B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2160090A1 (en) | 2001-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA74346C2 (en) | Aminodicarboxylic acids derivatives, use thereof and a medicament | |
MX9602683A (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances. | |
MX9601399A (en) | Benzocyclopentane oxazolidones containing heteroatoms, process for their production and medicaments containing them. | |
CA2257329A1 (en) | Nebulized budesonide for the treatment of respiratory diseases | |
CA2272584A1 (en) | Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases | |
MXPA03007712A (en) | Pharmaceutical salts. | |
ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
ATE205086T1 (en) | USE OF THE CHELATING AGENT CLIOQUINOL FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
WO2001085715A3 (en) | Aza- and polyazanthranyl amides and their use as medicaments | |
AU1122202A (en) | Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis | |
HU9602668D0 (en) | Progesterone antagonists useful preparing medicaments for treating dysfunctional uterine bleeding | |
IS2135B (en) | Medicinal product containing solmitriptan | |
IL150528A0 (en) | Ibuprofen containing active agent preparation | |
AU5372199A (en) | Cyclopentabenzofuran derivatives and their use | |
MA26899A1 (en) | PREPARATIONS CONTAINING A GLUCOCORTICOID MEDICAMENT FOR THE TREATMENT OF BRONCHOPULMONARY DISEASES. | |
WO2000062798A3 (en) | Angiogenic growth factors for treatment of peripheral neuropathy | |
PL348781A1 (en) | Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition | |
GB9909135D0 (en) | Cystic fibrosis medicaments | |
ES2160090B1 (en) | Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration | |
WO2002053149A3 (en) | Medicament containing a polyamine as an active substance | |
NZ334571A (en) | Pharmaceutical composition comprising 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy-acetic acid for treating diseases induced by respiratory syncytial virus | |
WO2001076590A3 (en) | Treatment for benign positional vertigo using antiepileptics | |
DE69941897D1 (en) | MEDICINAL PRODUCT FOR NON-CARDIOGENIC DIASTOLIC DYSFUNCTION | |
MY127328A (en) | 5-amino-1-pentene-3-ol substituted derivatives | |
WO2002041897A3 (en) | Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20011016 Kind code of ref document: A1 Effective date: 20011016 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20200626 |